CoronaryAtlas logo
CoronaryAtlas
Fibroblast growth factor receptor 1
Pathway / Endothelial activation & erosion

Fibroblast growth factor receptor 1

FGFR1protein

FGFR1 mediates fibroblast growth factor signaling in endothelial cells, influencing plaque vascularization, inflammation, and atherothrombotic vulnerability.

Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleFGF signaling modulates endothelial function, angiogenesis, and vascular remodeling relevant to atherosclerotic plaque evolution.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates26
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000077782

Type I vs Type II discrimination

ScoresIndeterminate
R — rupture / Type-I
—
C — confounder / Type-II
33
A — assay feasibility
72
E — evidence strength
50
T1DI (composite)
15
Specificity differential (R−C)-18.3
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 1
2anemia / acute blood lossn/a
3hypovolemia / dehydrationn/a
4tachyarrhythmian/a
5hypoxemia / respiratory failuren/a
6hypertensive emergencyn/a
7high-demand / peri-operative stressn/a
Coverage: 1/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 1 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(1)